Industry News
Critical mass key to investor support: Vernalis CEO
Small biotech companies face investor resistance to mergers and acquisitions, a leading British biotech CEO told attendees at a briefing in Melbourne on Tuesday. [ + ]
UK firm Vernalis testing Monash painkiller
New British biotech company Vernalis expects to complete Phase I clinical trials of a powerful new painkiller discovered by Monash University scientists by the middle of next year. [ + ]
Milestone strategic agreement to commercialise Australian biotech innovation
Benitec Limited, CSIRO and the Queensland Department of Primary Industries, have announced a strategic agreement that will accelerate Australia's lead in the global commercialisation of DNA Directed RNA interference, a breakthrough gene silencing technology.
[ + ]CogState aims to raise $5.5m at IPO
The latest company to jump on the IPO bandwagon is CogState, which filed its prospectus with the ASX mid-last week. [ + ]
Our first genome: Leptospira genome completed
Australian researchers have their first bug in the bank: a full genome map and complete DNA sequence of the 3900-odd genes that make up the spirochete bacterium Leptospira. [ + ]
Pulsar find boosts hope for gravity-wave hunters
A discovery made with CSIRO's Parkes radio telescope in eastern Australia may have brought forward the day when astronomers will directly detect cosmic gravity waves for the first time.
[ + ]Scientists refute aspects of UK Farm Scale GM study
A group of leading international agricultural and food scientists says increased food production by GM herbicide-tolerant crops could actually benefit the environment and enhance biodiversity in Britain and Europe by allowing unused farmland to rededicated as conservation reserves. [ + ]
Cluster power ending Australia's research computing drought
If computing power were water, Australia's drought would be rapidly coming to a close. Thanks to lowering costs and steadily improving technology, Australian life scientists and other researchers are rapidly gaining access to unprecedented amounts of computing power to support their work. [ + ]
Novogen subsidiary raises US$10m
Marshall Edwards, the US subsidiary of Novogen (ASX:NRT), has raised US$10.1 million through the exercise of expiring warrants by shareholders. [ + ]
Florigene to be sold to Suntory as Nufarm exits biotech
Australian biotechnology pioneer Florigene, a subsidiary of Australian agricultural company Nufarm, is being sold off to long-time joint venture partner Suntory. [ + ]
'Open-source biology' stance earns international honour
Maverick molecular geneticist Richard Jefferson is in New York this week to accept a prestigious Scientific American award as one of the magazine's 50 Global Technology Leaders of 2003. [ + ]
New Bionomics mouse model shows epilepsy writ small
When Florey Institute epilepsy researcher Dr Steve Petrou showed the electroencephalogram trace to his colleague, Prof Sam Berkovic, the veteran clinician recognised it immediately. [ + ]
Lessons in coping with strees from yeast
The humble yeast can provide vital lessons in coping with stress, according to researchers from the University of Newcastle upon Tyne in England. Dr Jan Quinn told delegates at a meeting of the Society for General Biology how she and colleagues have tracked stress responses in yeast to give a new understanding of how cells cope with oxidative stress.
[ + ]Meditech raises $2.2m in share purchase plan
Meditech Research (ASX:MRL) has added AUD$2 million to its coffers through a shareholder purchase plan, bringing the total capital raised recently to $6.8 million. [ + ]
QUT team develops rapid staph test
A Queensland research team has developed the world's first rapid DNA test to identify methicillin resistant Staphylococcus aureus (MRSA). [ + ]